Delivery Order SPE2DR25D2014-SPE2DR26FZ80T
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Epinephrine 0.3 mg auto-injector 2-packs, with a contract ceiling value of $2,035.08. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 12, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of Epinephrine 0.3 mg auto-injector two-packs, with a ceiling value of $2,341.44 and ultimate completion date of November 26, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award to this established pharmaceutical distributor. The place of performance is listed as the contractor's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Epinephrine 0.3 mg auto-injector two-packs, with a ceiling value of $1,767.06 and an ultimate completion date of December 16, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. The award represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of epinephrine 0.3 mg auto-injector 2-packs. This competitively awarded, non-set-aside contract carries a ceiling value of $1,288.24 and has a firm fixed price structure with an ultimate completion date of November 17, 2025. The award was issued from the company's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of epinephrine 0.3 mg auto-injector (2-pack) with a ceiling value of $4,493.10. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is scheduled for completion by October 31, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Epinephrine 0.3 mg auto-injector packs (two units per pack). This firm fixed price delivery order, valued at $4,035.65, represents a non-set-aside competitive award with an ultimate completion date of October 28, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for epinephrine 0.3 mg auto-injector (2-pack) on August 11, 2025, with a ceiling value of $3,712.80 and ultimate completion date of August 12, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The contract represents a small transaction within AmerisourceBergen's broader...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for epinephrine 0.3 mg auto-injector two-packs with a ceiling value of $1,249.56. This firm fixed-price delivery order, which was not set-aside and competitively awarded, was issued on September 18, 2025, with an ultimate completion date of September 19, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on May 16, 2025, for the supply of Epinephrine 0.3 mg auto-injector two-packs, with a ceiling value of $1,614.81 and a completion date of May 19, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and represents a continuation of AmerisourceBergen's extensive role as a critical pharmaceutical and medical supply vendor to federal...
- The Defense Logistics Agency awarded a $1,775.97 firm fixed-price delivery order to AmerisourceBergen Drug Corp for epinephrine 0.3 mg auto-injector 2-packs on December 16, 2025, with completion due by December 17, 2025. This non-set-aside contract is a child order issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The company, headquartered in Conshohocken, Pennsylvania,...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FZ80TDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of Epinephrine 0.3 mg auto-injector two-packs, valued at $5,707.80. This firm fixed-price delivery order, with an ultimate completion date of November 26, 2025, will be fulfilled from the vendor's Conshohocken, Pennsylvania location. The contract was awarded on a competitive basis with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to meet federal pharmaceutical procurement requirements. This delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a $999.99 billion ceiling through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of medications and medical supplies to military healthcare programs and other federal health systems. AmerisourceBergen's extensive portfolio of federal medical contracts demonstrates its critical role as a pharmaceutical distributor supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.7k | 11/24/25 |